- $3.11bn
- $3.01bn
- $158.32m
United Therapeutics falls on quarterly profit miss
Liquidia Corp reports results for the quarter ended September 30 - Earnings Summary
Liquidia Corp expected to post a loss of 37 cents a share - Earnings Preview
Liquidia Corp expected to post a loss of 37 cents a share - Earnings Preview
Brief: Liquidia Corp United Therapeutics Filed New Cross-Claims In FDA Suit Against FDA
U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley
U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera
Liquidia down after challenging regulatory exclusivity for rival's inhaled drug
U.S. STOCKS ON THE MOVE-Snowflake, Zoom, Synopsys
U.S. STOCKS ON THE MOVE-Wolfspeed, Synopsys, Zuora
Brief: Liquidia Says Files Litigation To Challenge Regulatory Exclusivity Blocking Access To Yutrepi Inhalation Powder For Patients Suffering With Pah And Ph-Ild
Liquidia down after co challenges regulatory exclusivity for rival's inhaled drug
Liquidia challenges regulatory exclusivity for rival's inhaled drug (updated)
Liquidia files litigation challenging regulatory exclusivity for rival's inhaled drug
U.S. RESEARCH ROUNDUP- Alight, Mastercard, Visa
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
U.S. STOCKS ON THE MOVE- Newpark Resources, Sonder Holdings, HP Inc
U.S. STOCKS ON THE MOVE- Advanced Micro Devices, Liquidia, Xperi